Skip to main content
Erschienen in: Journal of Clinical Immunology 4/2016

17.03.2016 | Letter to Editor

Visceral Leishmaniasis May Unmask X-linked Hyper-IgM Syndrome

verfasst von: Luis Ignacio Gonzalez-Granado, Nerea Dominguez-Pinilla, Fernando Gallego-Bustos, Jesús Ruiz-Contreras, Luis M. Allende

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Excerpt

We report a 4-year old male born to non-consanguineous Caucasian parents, suffering from recurrent pneumonia since since the age of 5 months, including an episode of multilobar pneumonia requiring Pediatric Intensive Care Unit (PICU) admission. At 16 month-old he suffered from pneumococcal sepsis and pneumonia; humoral immunodeficiency was suspected at that time. The patient had impaired antibody response to polysaccharides and protein antigens. Nephelometry revealed IgG serum levels below the third percentile, with absent IgA and normal IgM concentration. Flow cytometry showed adequate T-cell phenotype but altered B-cell compartment due to lack of memory B-cells suggesting a class switch recombination (CSR) defect. Additionally, CD40L expression upon T-cell activation was impaired (Fig. 1 a). Lymphoproliferative function was normal (PHA, CD3 and PMA + ionomycin -data not shown-). Gene sequencing yielded a novel mutation in CD40LG, a duplication of G in codon 167 (c.dup500) leading to stop in codon 200, causing X-linked Hyper IgM (X-HIGM) also known as Hyper IgM type 1 (Fig. 1 b). [ 1] Intravenous gammaglobulin replacement was started maintaining serum Ig levels over 600 mg/dl.One year after diagnosis of X-HIGM, he was admitted because of 9-day fever with no other symptoms. Physical exam revealed fever of 39.5 °C in a well-appearing child. His spleen was enlarged extending 3 cm below the left costal margin. WBC revealed pancytopenia with no blasts in peripheral blood smear. Bone marrow aspirate showed macrophages with intracellular forms of Leishmania amastigotes, and a diagnosis of visceral leishmaniasis was made, so Visceral Leishmaniasis was diagnosed (PCR techniques were unavailable at that time). He was treated with liposomal amphotericin B, 4 mg/kg daily for two weeks, then monthly for the next twelve months. He became afebrile 48 h after receiving the first dose of liposomal B amphotericin. No recurrence of leishmaniasis were observed for 6 years.
Literatur
1.
Zurück zum Zitat Lee WI, Torgerson TR, Schumacher MJ, et al. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105(5):1881–90. CrossRefPubMed Lee WI, Torgerson TR, Schumacher MJ, et al. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105(5):1881–90. CrossRefPubMed
2.
Zurück zum Zitat Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine ( Baltimore). 2003;82(6):373–84. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine ( Baltimore). 2003;82(6):373–84.
5.
Zurück zum Zitat Qamar N, Fuleihan RL. The hyper IgM syndromes. Clin Rev Allergy Immunol. 2014;46(2):120–30. CrossRefPubMed Qamar N, Fuleihan RL. The hyper IgM syndromes. Clin Rev Allergy Immunol. 2014;46(2):120–30. CrossRefPubMed
6.
Zurück zum Zitat Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 1996;4(3):283–9. CrossRefPubMed Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 1996;4(3):283–9. CrossRefPubMed
7.
Zurück zum Zitat de Oliveira FA, Barreto AS, Bomfim LGS, Leite TRS, dos Santos PL, de Almeida RP, et al. Soluble CD40 Ligand in Sera of Subjects Exposed to Leishmania infantum Infection Reduces the Parasite Load in Macrophages. PLoS One. 2015;10(10):e0141265. CrossRefPubMedPubMedCentral de Oliveira FA, Barreto AS, Bomfim LGS, Leite TRS, dos Santos PL, de Almeida RP, et al. Soluble CD40 Ligand in Sera of Subjects Exposed to Leishmania infantum Infection Reduces the Parasite Load in Macrophages. PLoS One. 2015;10(10):e0141265. CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Padigel UM, Farrell JP. CD40-CD40 ligand costimulation is not required for initiation and maintenance of a Th1-type response to Leishmania major infection. Infect Immun. 2003;71(3):1389–95. CrossRefPubMedPubMedCentral Padigel UM, Farrell JP. CD40-CD40 ligand costimulation is not required for initiation and maintenance of a Th1-type response to Leishmania major infection. Infect Immun. 2003;71(3):1389–95. CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Martin JC, Sancho T, Sierra FJ, et al. Visceral Leishmaniasis in a Patient with Hyper-IgM Hypogammaglobulinemia. Clin Inf Dis. 1996;23:1189–91. CrossRef Martin JC, Sancho T, Sierra FJ, et al. Visceral Leishmaniasis in a Patient with Hyper-IgM Hypogammaglobulinemia. Clin Inf Dis. 1996;23:1189–91. CrossRef
10.
Zurück zum Zitat Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C. Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2014;5:162. PubMedPubMedCentral Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C. Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2014;5:162. PubMedPubMedCentral
Metadaten
Titel
Visceral Leishmaniasis May Unmask X-linked Hyper-IgM Syndrome
verfasst von
Luis Ignacio Gonzalez-Granado
Nerea Dominguez-Pinilla
Fernando Gallego-Bustos
Jesús Ruiz-Contreras
Luis M. Allende
Publikationsdatum
17.03.2016
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 4/2016
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-016-0270-9

Weitere Artikel der Ausgabe 4/2016

Journal of Clinical Immunology 4/2016 Zur Ausgabe

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.